ALCHYMARS ICM SM PRIVATE LTD

Overview

ALCHYMARS ICM SM PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering 6-METHYLENE ANDROST-4-ENE-3, 17-DIONE (6-MAD) DRUG SUBSTANCE INTERMEDIATE; ATOVAQUONE USP; CLINDAMYCIN HYDROCHLORIDE, USP; RISEDRONATE SODIUM USP; SODIUM NITROPRUSSIDE USP; WARFARIN SODIUM USP.

API / Drug Master Files

ALCHYMARS ICM SM PRIVATE LTD holds 6 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• 6-METHYLENE ANDROST-4-ENE-3, 17-DIONE (6-MAD) DRUG SUBSTANCE INTERMEDIATEActive2014-05-06
• SODIUM NITROPRUSSIDE USPActive2013-12-27
• RISEDRONATE SODIUM USPActive2011-01-31
• WARFARIN SODIUM USPActive2008-12-10
• ATOVAQUONE USPActive2008-10-01
• CLINDAMYCIN HYDROCHLORIDE, USPActive2006-02-14

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to ALCHYMARS ICM SM PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.